Annual report pursuant to Section 13 and 15(d)

Subsequent Events

Subsequent Events
12 Months Ended
Dec. 31, 2015
Subsequent Events [Abstract]  
Subsequent Events


On March 10, 2016, Merck KGaA and the Company agreed to terminate the global license and co development agreement, or License Agreement, pursuant to a termination agreement, or the Termination Agreement.  Under the terms of the Termination Agreement, all rights under the License Agreement were returned to the Company, as well as all rights to Merck KGaA technology developed under the License Agreement.  See Note 3, “Collaboration Arrangement” for a further discussion.